Long-term trends in the incidence of and survival with heart failure

New England Journal of Medicine

Volumn 347, Issue 18, 2002, Pages 1397-1402

  Levy, Daniel ^a   Kenchaiah, Satish ^a   Glarson, Martin ^b   Benjamin, Emelia J ^b   J kupka, Michelle ^c   Ho, Kalon K L ^d   Murabito, Joanne M ^e   Vasan, Ramachandran S ^a,f  

^a FRAMINGHAM HEART STUDY   (United States)

^b Sections of Preventive Medicine   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; FEMALE; HEART FAILURE; HUMAN; INCIDENCE; LONG TERM CARE; MALE; MORTALITY; PRIORITY JOURNAL; SEX RATIO; STATISTICAL MODEL; SURVIVAL RATE;

ADULT; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; RISK; SURVIVAL RATE; SURVIVORS;

EID: 0037206364     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa020265     Document Type: Article

References (40)

1. 2002 Heart and Stroke Statistical Update. Dallas: American Heart Association, 2001.
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
3. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
4. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9, [Erratum, Hypertension 1996;27:1192.]
5. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;314:1547-52.
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-35.
7. The SOLVD Investigators. Effect ofenalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
8. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
9. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
10. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 1999;353:9-13.
11. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709-17
12. Philbin EE Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol 1998;21:103-8.
13. Di Lenarda A, Secoli G, Perkan A, et al. Changing mortality in dilated cardiomyopathy. Br Heart J 1994;72:Suppl:S46-S51.
14. Stevenson WG, Stevenson LW, Middlekauff HR, et al. Improving survival for patients with advanced heart failure: A study of 737 consecutive patients. J Am Coll Cardiol 1995;26:1417-23.
15. MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 2000;102:1126-31.
16. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993;88:107-15.
17. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: Trends in incidence and survival in a 10-year period. Arch Intern Med 1999;159:29-34.
18. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health 1951;41:279-86.
19. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: The Framingham Offspring Study. Am J Epidemiol 1979;110:281-90.
20. Kannel WB, Wolf PA, Garrison RJ. The Framingharn Study: An Epidemiological Investigation of Cardiovascular Disease. Section 34. Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-Year Followup. Bethesda, Md.: National Heart, Lung, and Blood Institute, 1987. (NIH publication no. 87-2703.)
21. Shurtleff D. Some Characteristics Related to the Incidence of Cardiovascular Disease and Death: Framingham Heart Study 18-Year Follow-up. Washington, D.C.: Government Printing Office, 1974:7-25.
22. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971;285:1441-6.
23. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46. [Erratum, Arch Intern Med 1998;158:573.]
24. Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: The Framingham Study. Ann Intern Med 1970;72:813-22.
25. Cox DR. Regression models and life-tables. J R Stat [B] 1972;34:187-220.
26. SAS/STAT Software: Changes and Enhancements Through Release 6.12. Cary, N.C.: SAS Institute, 1997.
27. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
28. Mosterd A, D'Agostino RB, Silbershatz H, et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med 1999;340:1221-7.
29. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timmis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ 1993;307:349-53. [Erratum, EMJ 1993;307:909.
30. Baker DW, Jones R, Hodges J, Massie BM, Konstam MA, Rose EA. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systclic dysfunction. JAMA 1994;272:1528-34.
31. Morrison AS. The effects of early treatment, lead time and length bias on the mortality experienced by cases detected by screening. Int J Epidemiol 1982;11:261.7.
32. Simborg DW. DRG creep: A new hospital-acquired disease. N Engl J Med 1981;304:1602-4.
33. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-6.
34. Brophy JM. Epidemiology of congestive heart failure: Canadian data from 1970 to 1989. Can J Cardiol 1992;8:495-8.
35. Rodriguez-Artalejo F, Guallar-Castillon P, Banegas Banegas JR, del Rey Calero J. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J 1997;18:1771-9.
36. Murdoch DR, Love MP, Robb SD, et al. Importance of heart failure as a cause of death: Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979-1992. Eur Heart, J 1998;19:1829-35.
37. Fact Book: Fiscal Year 2001. Bethesda, Md.: National Heart, Lung, and Blood Institute, 2002.
38. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Bajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
39. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994;72:Suppl:S3-S9.
40. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective. J Am Coll Cardiol 1995;26:1565-74.